Global Drug Eluting Stents (DES) Market Research Report 2025(Status and Outlook)

March 2025 | 188 pages | ID: G576A92B0378EN
Bosson Research

Abstracts

Report Overview

Drug Eluting Stents (DES) are medical devices used in the treatment of coronary artery disease. These stents are designed to prevent restenosis, which is the re-narrowing of the arteries after a stent has been inserted. DES are coated with medication that is slowly released into the surrounding tissue, helping to reduce inflammation and inhibit cell proliferation. This innovative technology has significantly improved the outcomes of patients undergoing coronary artery stenting procedures by reducing the need for repeat interventions.

The market for Drug Eluting Stents (DES) is experiencing steady growth due to several key market trends and drivers. One major trend is the increasing prevalence of coronary artery disease worldwide, driven by factors such as aging populations, sedentary lifestyles, and unhealthy dietary habits. As a result, there is a growing demand for minimally invasive treatment options like DES. Additionally, advancements in stent design and drug coatings are improving the efficacy and safety of DES, further driving market growth. Moreover, the rising adoption of DES in emerging markets, along with increasing investments in healthcare infrastructure, is expected to fuel market expansion. At the same time, ongoing research and development efforts aimed at enhancing the performance of DES are likely to open up new opportunities for market players.

This report provides a deep insight into the global Drug Eluting Stents (DES) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Eluting Stents (DES) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Eluting Stents (DES) market in any manner.

Global Drug Eluting Stents (DES) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Vascular

Advantec Vascular

B.Braun Melsengen AG

Biosensors

Biotronik

Blue Medical

Boston Scientific

DISA Vascular

Essen

Medtronic Vascular

MicroPort Medical

MIV Therapeutics

Orbusneich

Promed Medical

Relisys Medical

Reva Medical

Sahajanand

Sino Medical

Sorin

Terumo Medical

Market Segmentation (by Type)

Cobalt-chromium Alloy Stents

Magnesium Alloy Stents

Tyrosine Polycarbonate Stents

Nitinol Stents

Platinum Chromium Alloy Stents

Stainless Steel Stents

Other Materials

Market Segmentation (by Application)

Coronary Heart Disease

Clinical

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Drug Eluting Stents (DES) Market
• Overview of the regional outlook of the Drug Eluting Stents (DES) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Eluting Stents (DES) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Drug Eluting Stents (DES)
1.2 Key Market Segments
  1.2.1 Drug Eluting Stents (DES) Segment by Type
  1.2.2 Drug Eluting Stents (DES) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 DRUG ELUTING STENTS (DES) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Drug Eluting Stents (DES) Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Drug Eluting Stents (DES) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 DRUG ELUTING STENTS (DES) MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Drug Eluting Stents (DES) Product Life Cycle
3.3 Global Drug Eluting Stents (DES) Sales by Manufacturers (2020-2025)
3.4 Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug Eluting Stents (DES) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Drug Eluting Stents (DES) Manufacturing Sites, Area Served, Product Type
3.8 Drug Eluting Stents (DES) Market Competitive Situation and Trends
  3.8.1 Drug Eluting Stents (DES) Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Drug Eluting Stents (DES) Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 DRUG ELUTING STENTS (DES) INDUSTRY CHAIN ANALYSIS

4.1 Drug Eluting Stents (DES) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF DRUG ELUTING STENTS (DES) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Drug Eluting Stents (DES) Market
5.7 ESG Ratings of Leading Companies

6 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Eluting Stents (DES) Sales Market Share by Type (2020-2025)
6.3 Global Drug Eluting Stents (DES) Market Size Market Share by Type (2020-2025)
6.4 Global Drug Eluting Stents (DES) Price by Type (2020-2025)

7 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Eluting Stents (DES) Market Sales by Application (2020-2025)
7.3 Global Drug Eluting Stents (DES) Market Size (M USD) by Application (2020-2025)
7.4 Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)

8 DRUG ELUTING STENTS (DES) MARKET SALES BY REGION

8.1 Global Drug Eluting Stents (DES) Sales by Region
  8.1.1 Global Drug Eluting Stents (DES) Sales by Region
  8.1.2 Global Drug Eluting Stents (DES) Sales Market Share by Region
8.2 Global Drug Eluting Stents (DES) Market Size by Region
  8.2.1 Global Drug Eluting Stents (DES) Market Size by Region
  8.2.2 Global Drug Eluting Stents (DES) Market Size Market Share by Region
8.3 North America
  8.3.1 North America Drug Eluting Stents (DES) Sales by Country
  8.3.2 North America Drug Eluting Stents (DES) Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Drug Eluting Stents (DES) Sales by Country
  8.4.2 Europe Drug Eluting Stents (DES) Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Drug Eluting Stents (DES) Sales by Region
  8.5.2 Asia Pacific Drug Eluting Stents (DES) Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Drug Eluting Stents (DES) Sales by Country
  8.6.2 South America Drug Eluting Stents (DES) Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Drug Eluting Stents (DES) Sales by Region
  8.7.2 Middle East and Africa Drug Eluting Stents (DES) Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 DRUG ELUTING STENTS (DES) MARKET PRODUCTION BY REGION

9.1 Global Production of Drug Eluting Stents (DES) by Region(2020-2025)
9.2 Global Drug Eluting Stents (DES) Revenue Market Share by Region (2020-2025)
9.3 Global Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug Eluting Stents (DES) Production
  9.4.1 North America Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
  9.4.2 North America Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug Eluting Stents (DES) Production
  9.5.1 Europe Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
  9.5.2 Europe Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug Eluting Stents (DES) Production (2020-2025)
  9.6.1 Japan Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
  9.6.2 Japan Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug Eluting Stents (DES) Production (2020-2025)
  9.7.1 China Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
  9.7.2 China Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Abbott Vascular
  10.1.1 Abbott Vascular Basic Information
  10.1.2 Abbott Vascular Drug Eluting Stents (DES) Product Overview
  10.1.3 Abbott Vascular Drug Eluting Stents (DES) Product Market Performance
  10.1.4 Abbott Vascular Business Overview
  10.1.5 Abbott Vascular SWOT Analysis
  10.1.6 Abbott Vascular Recent Developments
10.2 Advantec Vascular
  10.2.1 Advantec Vascular Basic Information
  10.2.2 Advantec Vascular Drug Eluting Stents (DES) Product Overview
  10.2.3 Advantec Vascular Drug Eluting Stents (DES) Product Market Performance
  10.2.4 Advantec Vascular Business Overview
  10.2.5 Advantec Vascular SWOT Analysis
  10.2.6 Advantec Vascular Recent Developments
10.3 B.Braun Melsengen AG
  10.3.1 B.Braun Melsengen AG Basic Information
  10.3.2 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
  10.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Market Performance
  10.3.4 B.Braun Melsengen AG Business Overview
  10.3.5 B.Braun Melsengen AG SWOT Analysis
  10.3.6 B.Braun Melsengen AG Recent Developments
10.4 Biosensors
  10.4.1 Biosensors Basic Information
  10.4.2 Biosensors Drug Eluting Stents (DES) Product Overview
  10.4.3 Biosensors Drug Eluting Stents (DES) Product Market Performance
  10.4.4 Biosensors Business Overview
  10.4.5 Biosensors Recent Developments
10.5 Biotronik
  10.5.1 Biotronik Basic Information
  10.5.2 Biotronik Drug Eluting Stents (DES) Product Overview
  10.5.3 Biotronik Drug Eluting Stents (DES) Product Market Performance
  10.5.4 Biotronik Business Overview
  10.5.5 Biotronik Recent Developments
10.6 Blue Medical
  10.6.1 Blue Medical Basic Information
  10.6.2 Blue Medical Drug Eluting Stents (DES) Product Overview
  10.6.3 Blue Medical Drug Eluting Stents (DES) Product Market Performance
  10.6.4 Blue Medical Business Overview
  10.6.5 Blue Medical Recent Developments
10.7 Boston Scientific
  10.7.1 Boston Scientific Basic Information
  10.7.2 Boston Scientific Drug Eluting Stents (DES) Product Overview
  10.7.3 Boston Scientific Drug Eluting Stents (DES) Product Market Performance
  10.7.4 Boston Scientific Business Overview
  10.7.5 Boston Scientific Recent Developments
10.8 DISA Vascular
  10.8.1 DISA Vascular Basic Information
  10.8.2 DISA Vascular Drug Eluting Stents (DES) Product Overview
  10.8.3 DISA Vascular Drug Eluting Stents (DES) Product Market Performance
  10.8.4 DISA Vascular Business Overview
  10.8.5 DISA Vascular Recent Developments
10.9 Essen
  10.9.1 Essen Basic Information
  10.9.2 Essen Drug Eluting Stents (DES) Product Overview
  10.9.3 Essen Drug Eluting Stents (DES) Product Market Performance
  10.9.4 Essen Business Overview
  10.9.5 Essen Recent Developments
10.10 Medtronic Vascular
  10.10.1 Medtronic Vascular Basic Information
  10.10.2 Medtronic Vascular Drug Eluting Stents (DES) Product Overview
  10.10.3 Medtronic Vascular Drug Eluting Stents (DES) Product Market Performance
  10.10.4 Medtronic Vascular Business Overview
  10.10.5 Medtronic Vascular Recent Developments
10.11 MicroPort Medical
  10.11.1 MicroPort Medical Basic Information
  10.11.2 MicroPort Medical Drug Eluting Stents (DES) Product Overview
  10.11.3 MicroPort Medical Drug Eluting Stents (DES) Product Market Performance
  10.11.4 MicroPort Medical Business Overview
  10.11.5 MicroPort Medical Recent Developments
10.12 MIV Therapeutics
  10.12.1 MIV Therapeutics Basic Information
  10.12.2 MIV Therapeutics Drug Eluting Stents (DES) Product Overview
  10.12.3 MIV Therapeutics Drug Eluting Stents (DES) Product Market Performance
  10.12.4 MIV Therapeutics Business Overview
  10.12.5 MIV Therapeutics Recent Developments
10.13 Orbusneich
  10.13.1 Orbusneich Basic Information
  10.13.2 Orbusneich Drug Eluting Stents (DES) Product Overview
  10.13.3 Orbusneich Drug Eluting Stents (DES) Product Market Performance
  10.13.4 Orbusneich Business Overview
  10.13.5 Orbusneich Recent Developments
10.14 Promed Medical
  10.14.1 Promed Medical Basic Information
  10.14.2 Promed Medical Drug Eluting Stents (DES) Product Overview
  10.14.3 Promed Medical Drug Eluting Stents (DES) Product Market Performance
  10.14.4 Promed Medical Business Overview
  10.14.5 Promed Medical Recent Developments
10.15 Relisys Medical
  10.15.1 Relisys Medical Basic Information
  10.15.2 Relisys Medical Drug Eluting Stents (DES) Product Overview
  10.15.3 Relisys Medical Drug Eluting Stents (DES) Product Market Performance
  10.15.4 Relisys Medical Business Overview
  10.15.5 Relisys Medical Recent Developments
10.16 Reva Medical
  10.16.1 Reva Medical Basic Information
  10.16.2 Reva Medical Drug Eluting Stents (DES) Product Overview
  10.16.3 Reva Medical Drug Eluting Stents (DES) Product Market Performance
  10.16.4 Reva Medical Business Overview
  10.16.5 Reva Medical Recent Developments
10.17 Sahajanand
  10.17.1 Sahajanand Basic Information
  10.17.2 Sahajanand Drug Eluting Stents (DES) Product Overview
  10.17.3 Sahajanand Drug Eluting Stents (DES) Product Market Performance
  10.17.4 Sahajanand Business Overview
  10.17.5 Sahajanand Recent Developments
10.18 Sino Medical
  10.18.1 Sino Medical Basic Information
  10.18.2 Sino Medical Drug Eluting Stents (DES) Product Overview
  10.18.3 Sino Medical Drug Eluting Stents (DES) Product Market Performance
  10.18.4 Sino Medical Business Overview
  10.18.5 Sino Medical Recent Developments
10.19 Sorin
  10.19.1 Sorin Basic Information
  10.19.2 Sorin Drug Eluting Stents (DES) Product Overview
  10.19.3 Sorin Drug Eluting Stents (DES) Product Market Performance
  10.19.4 Sorin Business Overview
  10.19.5 Sorin Recent Developments
10.20 Terumo Medical
  10.20.1 Terumo Medical Basic Information
  10.20.2 Terumo Medical Drug Eluting Stents (DES) Product Overview
  10.20.3 Terumo Medical Drug Eluting Stents (DES) Product Market Performance
  10.20.4 Terumo Medical Business Overview
  10.20.5 Terumo Medical Recent Developments

11 DRUG ELUTING STENTS (DES) MARKET FORECAST BY REGION

11.1 Global Drug Eluting Stents (DES) Market Size Forecast
11.2 Global Drug Eluting Stents (DES) Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Drug Eluting Stents (DES) Market Size Forecast by Country
  11.2.3 Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region
  11.2.4 South America Drug Eluting Stents (DES) Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Drug Eluting Stents (DES) by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Drug Eluting Stents (DES) Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Drug Eluting Stents (DES) by Type (2026-2033)
  12.1.2 Global Drug Eluting Stents (DES) Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Drug Eluting Stents (DES) by Type (2026-2033)
12.2 Global Drug Eluting Stents (DES) Market Forecast by Application (2026-2033)
  12.2.1 Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application
  12.2.2 Global Drug Eluting Stents (DES) Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Eluting Stents (DES) Market Size Comparison by Region (M USD)
Table 5. Global Drug Eluting Stents (DES) Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Drug Eluting Stents (DES) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Drug Eluting Stents (DES) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Stents (DES) as of 2024)
Table 10. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Drug Eluting Stents (DES) Manufacturing Sites and Area Served
Table 12. Manufacturers Drug Eluting Stents (DES) Product Type
Table 13. Global Drug Eluting Stents (DES) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Drug Eluting Stents (DES) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Drug Eluting Stents (DES) Sales by Type (K Units)
Table 25. Global Drug Eluting Stents (DES) Market Size by Type (M USD)
Table 26. Global Drug Eluting Stents (DES) Sales (K Units) by Type (2020-2025)
Table 27. Global Drug Eluting Stents (DES) Sales Market Share by Type (2020-2025)
Table 28. Global Drug Eluting Stents (DES) Market Size (M USD) by Type (2020-2025)
Table 29. Global Drug Eluting Stents (DES) Market Size Share by Type (2020-2025)
Table 30. Global Drug Eluting Stents (DES) Price (USD/Unit) by Type (2020-2025)
Table 31. Global Drug Eluting Stents (DES) Sales (K Units) by Application
Table 32. Global Drug Eluting Stents (DES) Market Size by Application
Table 33. Global Drug Eluting Stents (DES) Sales by Application (2020-2025) & (K Units)
Table 34. Global Drug Eluting Stents (DES) Sales Market Share by Application (2020-2025)
Table 35. Global Drug Eluting Stents (DES) Market Size by Application (2020-2025) & (M USD)
Table 36. Global Drug Eluting Stents (DES) Market Share by Application (2020-2025)
Table 37. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
Table 38. Global Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 39. Global Drug Eluting Stents (DES) Sales Market Share by Region (2020-2025)
Table 40. Global Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 41. Global Drug Eluting Stents (DES) Market Size Market Share by Region (2020-2025)
Table 42. North America Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 43. North America Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 45. Europe Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 48. South America Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 49. South America Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 52. Global Drug Eluting Stents (DES) Production (K Units) by Region(2020-2025)
Table 53. Global Drug Eluting Stents (DES) Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Drug Eluting Stents (DES) Revenue Market Share by Region (2020-2025)
Table 55. Global Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Abbott Vascular Basic Information
Table 61. Abbott Vascular Drug Eluting Stents (DES) Product Overview
Table 62. Abbott Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Abbott Vascular Business Overview
Table 64. Abbott Vascular SWOT Analysis
Table 65. Abbott Vascular Recent Developments
Table 66. Advantec Vascular Basic Information
Table 67. Advantec Vascular Drug Eluting Stents (DES) Product Overview
Table 68. Advantec Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Advantec Vascular Business Overview
Table 70. Advantec Vascular SWOT Analysis
Table 71. Advantec Vascular Recent Developments
Table 72. B.Braun Melsengen AG Basic Information
Table 73. B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
Table 74. B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. B.Braun Melsengen AG Business Overview
Table 76. B.Braun Melsengen AG SWOT Analysis
Table 77. B.Braun Melsengen AG Recent Developments
Table 78. Biosensors Basic Information
Table 79. Biosensors Drug Eluting Stents (DES) Product Overview
Table 80. Biosensors Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Biosensors Business Overview
Table 82. Biosensors Recent Developments
Table 83. Biotronik Basic Information
Table 84. Biotronik Drug Eluting Stents (DES) Product Overview
Table 85. Biotronik Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Biotronik Business Overview
Table 87. Biotronik Recent Developments
Table 88. Blue Medical Basic Information
Table 89. Blue Medical Drug Eluting Stents (DES) Product Overview
Table 90. Blue Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Blue Medical Business Overview
Table 92. Blue Medical Recent Developments
Table 93. Boston Scientific Basic Information
Table 94. Boston Scientific Drug Eluting Stents (DES) Product Overview
Table 95. Boston Scientific Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Boston Scientific Business Overview
Table 97. Boston Scientific Recent Developments
Table 98. DISA Vascular Basic Information
Table 99. DISA Vascular Drug Eluting Stents (DES) Product Overview
Table 100. DISA Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. DISA Vascular Business Overview
Table 102. DISA Vascular Recent Developments
Table 103. Essen Basic Information
Table 104. Essen Drug Eluting Stents (DES) Product Overview
Table 105. Essen Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Essen Business Overview
Table 107. Essen Recent Developments
Table 108. Medtronic Vascular Basic Information
Table 109. Medtronic Vascular Drug Eluting Stents (DES) Product Overview
Table 110. Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Medtronic Vascular Business Overview
Table 112. Medtronic Vascular Recent Developments
Table 113. MicroPort Medical Basic Information
Table 114. MicroPort Medical Drug Eluting Stents (DES) Product Overview
Table 115. MicroPort Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. MicroPort Medical Business Overview
Table 117. MicroPort Medical Recent Developments
Table 118. MIV Therapeutics Basic Information
Table 119. MIV Therapeutics Drug Eluting Stents (DES) Product Overview
Table 120. MIV Therapeutics Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. MIV Therapeutics Business Overview
Table 122. MIV Therapeutics Recent Developments
Table 123. Orbusneich Basic Information
Table 124. Orbusneich Drug Eluting Stents (DES) Product Overview
Table 125. Orbusneich Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Orbusneich Business Overview
Table 127. Orbusneich Recent Developments
Table 128. Promed Medical Basic Information
Table 129. Promed Medical Drug Eluting Stents (DES) Product Overview
Table 130. Promed Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Promed Medical Business Overview
Table 132. Promed Medical Recent Developments
Table 133. Relisys Medical Basic Information
Table 134. Relisys Medical Drug Eluting Stents (DES) Product Overview
Table 135. Relisys Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Relisys Medical Business Overview
Table 137. Relisys Medical Recent Developments
Table 138. Reva Medical Basic Information
Table 139. Reva Medical Drug Eluting Stents (DES) Product Overview
Table 140. Reva Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Reva Medical Business Overview
Table 142. Reva Medical Recent Developments
Table 143. Sahajanand Basic Information
Table 144. Sahajanand Drug Eluting Stents (DES) Product Overview
Table 145. Sahajanand Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Sahajanand Business Overview
Table 147. Sahajanand Recent Developments
Table 148. Sino Medical Basic Information
Table 149. Sino Medical Drug Eluting Stents (DES) Product Overview
Table 150. Sino Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. Sino Medical Business Overview
Table 152. Sino Medical Recent Developments
Table 153. Sorin Basic Information
Table 154. Sorin Drug Eluting Stents (DES) Product Overview
Table 155. Sorin Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 156. Sorin Business Overview
Table 157. Sorin Recent Developments
Table 158. Terumo Medical Basic Information
Table 159. Terumo Medical Drug Eluting Stents (DES) Product Overview
Table 160. Terumo Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 161. Terumo Medical Business Overview
Table 162. Terumo Medical Recent Developments
Table 163. Global Drug Eluting Stents (DES) Sales Forecast by Region (2026-2033) & (K Units)
Table 164. Global Drug Eluting Stents (DES) Market Size Forecast by Region (2026-2033) & (M USD)
Table 165. North America Drug Eluting Stents (DES) Sales Forecast by Country (2026-2033) & (K Units)
Table 166. North America Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2033) & (M USD)
Table 167. Europe Drug Eluting Stents (DES) Sales Forecast by Country (2026-2033) & (K Units)
Table 168. Europe Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2033) & (M USD)
Table 169. Asia Pacific Drug Eluting Stents (DES) Sales Forecast by Region (2026-2033) & (K Units)
Table 170. Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region (2026-2033) & (M USD)
Table 171. South America Drug Eluting Stents (DES) Sales Forecast by Country (2026-2033) & (K Units)
Table 172. South America Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2033) & (M USD)
Table 173. Middle East and Africa Drug Eluting Stents (DES) Sales Forecast by Country (2026-2033) & (Units)
Table 174. Middle East and Africa Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2033) & (M USD)
Table 175. Global Drug Eluting Stents (DES) Sales Forecast by Type (2026-2033) & (K Units)
Table 176. Global Drug Eluting Stents (DES) Market Size Forecast by Type (2026-2033) & (M USD)
Table 177. Global Drug Eluting Stents (DES) Price Forecast by Type (2026-2033) & (USD/Unit)
Table 178. Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application (2026-2033)
Table 179. Global Drug Eluting Stents (DES) Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Drug Eluting Stents (DES)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Eluting Stents (DES) Market Size (M USD), 2024-2033
Figure 5. Global Drug Eluting Stents (DES) Market Size (M USD) (2020-2033)
Figure 6. Global Drug Eluting Stents (DES) Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug Eluting Stents (DES) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug Eluting Stents (DES) Product Life Cycle
Figure 13. Drug Eluting Stents (DES) Sales Share by Manufacturers in 2024
Figure 14. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers in 2024
Figure 15. Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug Eluting Stents (DES) Revenue in 2024
Figure 18. Industry Chain Map of Drug Eluting Stents (DES)
Figure 19. Global Drug Eluting Stents (DES) Market PEST Analysis
Figure 20. Global Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drug Eluting Stents (DES) Market Share by Type
Figure 27. Sales Market Share of Drug Eluting Stents (DES) by Type (2020-2025)
Figure 28. Sales Market Share of Drug Eluting Stents (DES) by Type in 2024
Figure 29. Market Size Share of Drug Eluting Stents (DES) by Type (2020-2025)
Figure 30. Market Size Share of Drug Eluting Stents (DES) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drug Eluting Stents (DES) Market Share by Application
Figure 33. Global Drug Eluting Stents (DES) Sales Market Share by Application (2020-2025)
Figure 34. Global Drug Eluting Stents (DES) Sales Market Share by Application in 2024
Figure 35. Global Drug Eluting Stents (DES) Market Share by Application (2020-2025)
Figure 36. Global Drug Eluting Stents (DES) Market Share by Application in 2024
Figure 37. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drug Eluting Stents (DES) Sales Market Share by Region (2020-2025)
Figure 39. Global Drug Eluting Stents (DES) Market Size Market Share by Region (2020-2025)
Figure 40. North America Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 43. North America Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drug Eluting Stents (DES) Market Size Market Share by Country in 2024
Figure 45. U.S. Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Drug Eluting Stents (DES) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drug Eluting Stents (DES) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drug Eluting Stents (DES) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 53. Europe Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drug Eluting Stents (DES) Market Size Market Share by Country in 2024
Figure 55. Germany Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Drug Eluting Stents (DES) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drug Eluting Stents (DES) Market Size Market Share by Region in 2024
Figure 68. China Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 79. South America Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 80. South America Drug Eluting Stents (DES) Market Size and Growth Rate (M USD)
Figure 81. South America Drug Eluting Stents (DES) Market Size Market Share by Country in 2024
Figure 82. Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drug Eluting Stents (DES) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drug Eluting Stents (DES) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drug Eluting Stents (DES) Production Market Share by Region (2020-2025)
Figure 103. North America Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Drug Eluting Stents (DES) Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Drug Eluting Stents (DES) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Drug Eluting Stents (DES) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Drug Eluting Stents (DES) Market Share Forecast by Type (2026-2033)
Figure 111. Global Drug Eluting Stents (DES) Sales Forecast by Application (2026-2033)
Figure 112. Global Drug Eluting Stents (DES) Market Share Forecast by Application (2026-2033)